2'-Fucosyllactose_SYNAURA_SYNAURA,HMO supplier,HMOs,Human Milk Oligosaccharides,2'-FL,LNnT,3'-SL, infant formula ingredient, nutritional raw material

中文

2'-Fucosyllactose(2'-FL)

Human Milk Oligosaccharides（HMOs）

Human milk oligosaccharides (HMOs) are the third largest solid component in breast milk and the largest active nutrient. Currently, more than 200 HMOs have been identified. Since oligosaccharides chains can be fucosylated or sialylated, they are usually divided into three categories：

（a）Fucosylated neutral HMO(35-50%)

（b）Nonfucosylated neutral HMO (42-55%)

（c）Sialylated HMO (12-14%)

Representative compounds of fucosylated neutral HMO——2'-Fucosyllactose(2'-FL)

The most abundant oligosaccharides in natural breast milk, about 30% of HMOs

The first HMO to pass the U.S. FDA safety assessment, with the most abundant scientific papers and clinical trials

Has irreplaceable physiological effects, covering three key functions: Intestinal, immunity and brain

Synaura HMOs Product Advantages

First Chinese company with dual certification from China and the U.S.

——China's first 2'-fucosyllactose (2-FL) product approved by both the Chinese National Health Commission and the U.S. FDA GRAS certification

The first company to obtain 99% high purity certification worldwide

——Certificated by authoritative third-party testing agencies, Synaura HMO sample can reach 99% purity and is structurally identical to the HMO extracted from Chinese breast milk*

Global leading patents layout

——A total of 50+ domestic and international patent applications, with 30+ patents granted to date. Patents

covering HMO strain development, process optimization, testing, and application, establish an independent

original research and development patent system.

Reference

1. Rousseaux, A., et al. (2021). Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. Frontiers in Immunology, 12, Article 801911.

2. 2′-Fucosyllactose. PubChem; National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/170484 (accessed 2025-09-01).

3. Zhu, Y., Wan, L., Li, W., Ni, D., Zhang, W., Yan, X., & Mu, W. (2020). Recent advances on 2'-fucosyllactose: Physiological properties, applications, and production approaches. Critical Reviews in Food Science and Nutrition. Advance online publication.

4. The certification results are sourced from third-party organizations, including the《2025 Certificate of Conformity Verification》and the《2023 2'-FL Chemical Structural Equivalence Experiment》; the analytical data is sourced from the GRAS application data submitted by various companies.

China Headquarters

Xiaowei Zhang:+86-13910088419(WeChat)

Wenqiang Wang:+86-13811202192(WeChat)

GLOBAL OFFICE

Xiaowei ZHANG: +86-13910088419(WeChat)

Xinhui LI: +86-18241587387(WeChat)

Official email

service@synaura.cn

Company Address

Floors 1-2, Building 2, Lane 500, Furonghua Road, Pudong New Area, Shanghai

沪ICP备2024048832号-1